Cinven's M&A Ambitions Over Stada Under Scrutiny, Advent and Others Circle

By stalking Stada, Cinven seems to be planning to use the German generics group as a base that can support later carve-outs of mature and undervalued products from larger pharma companies - but it faces a rival bidder in Advent, and more suitors could yet appear.